These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7000657)

  • 1. (A14-phenylalanine)insulin: a new synthetic analogue.
    Danho W; Sasaki A; Büllesbach E; Gattner HG; Wollmer A
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):747-54. PubMed ID: 7000657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (A1-phenylalanine) insulin: a new synthetic analogue.
    Danho W; Sasaki A; Büllesbach E; Föhles J; Gattner HG
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):735-46. PubMed ID: 7000656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B22-D-arginine]insulin: synthesis and biological properties.
    Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
    Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1449-60. PubMed ID: 6761262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthesis of [A 19-3-iodotyrosine] and [A 19-3,5-diiodotyrosine]insulin (porcine).
    Wieneke HJ; Danho W; Büllesbach EE; Gattner HG; Zahn H
    Hoppe Seylers Z Physiol Chem; 1983 May; 364(5):537-50. PubMed ID: 6347860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone.
    Chu YC; Zong L; Burke GT; Katsoyannis PG
    J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [B17-D-leucine]insulin and [B17-norleucine]insulin: synthesis and biological properties.
    Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
    Hoppe Seylers Z Physiol Chem; 1983 Nov; 364(11):1615-26. PubMed ID: 6363268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological properties of insulins with tyrosine replaced by phenylalanine at positions 14 and 19 of the A chain.
    Cockram CS; Jones RH; Sönksen PH
    Diabet Med; 1985 Jul; 2(4):241-4. PubMed ID: 2951075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of human [9-leucine-B] Insulin.
    Schwartz G; Katsoyannis PG
    Biochemistry; 1976 Sep; 15(18):4071-76. PubMed ID: 963021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [21-arginine-A] insulin: a biologically active analog.
    Ferderigos N; Cosmatos A; Ferderigos A; Katsoyannis PG
    Int J Pept Protein Res; 1979 Jan; 13(1):43-53. PubMed ID: 422323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preparation of porcine (Tyr-A14-2H) insulin and its characterization by mass spectrometry.
    Savoy LA; Vuagnat P; Rose K; Halstrøm J; Jørgensen KH; Kovacs K
    Protein Eng; 1988 Oct; 2(4):313-5. PubMed ID: 3074308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of [A19-(p-fluorophenylalanine)] insulin.
    Stoev S; Zakhariev S; Golovinsky E; Gattner HG; Naithani VK; Wollmer A; Brandenburg D
    Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1307-15. PubMed ID: 3072012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of two biologically active insulin analogues with modifications at the N-terminal and N- and C-terminal amino acid residues.
    Cosmatos A; Okada Y; Katsoyannis PG
    Biochemistry; 1976 Sep; 15(18):4076-82. PubMed ID: 963022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoiodoinsulin specifically substituted in Tyr A14 or Tyr A19.
    Linde S; Hansen B
    Int J Pept Protein Res; 1980 May; 15(5):495-502. PubMed ID: 7002822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
    Linde S; Sonne O; Hansen B; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):573-9. PubMed ID: 7024083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insulin analogue with gamma-amino butyric acid substitution for A13Leu-A14Tyr.
    Huang YD; Yang SZ; Feng YM; Niu CI
    J Pept Res; 1999 Jul; 54(1):18-22. PubMed ID: 10448966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT; Schwartz G; Katsoyannis PG
    Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
    Tager H; Thomas N; Assoian R; Rubenstein A; Saekow M; Olefsky J; Kaiser ET
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3181-5. PubMed ID: 6997872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human insulin: facile synthesis by modification of porcine insulin.
    Ruttenberg MA
    Science; 1972 Aug; 177(4049):623-6. PubMed ID: 5049307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the total synthesis of an A7,B7-dicarbainsulin. III. Assembly of segments and generation of biological activity.
    Videnov G; Büttner K; Casaretto M; Föhles J; Gattner HG; Stoev S; Brandenburg D
    Biol Chem Hoppe Seyler; 1990 Nov; 371(11):1057-66. PubMed ID: 2085412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.